Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
Getting strange calls or texts from “Amazon” after placing holiday gift orders? In this AARP Live Minute, experts from AARP reveal three Amazon imposter scams to watch out for as you navigate the holiday season.
Beekeepers across the nation face a common challenge during winter—helping bee colonies survive the harsh conditions. Now, a new product developed by an innovated apiarist is changing the game. Enter, the Hive Hugger.
As the USDA tracks how Plant Hardiness Zones are slowly shifting across the country, they are also adjusting their recommendations for gardeners when it comes to perennial plants. The data is also used the by Risk Management Agency to determine crop insurance rates.